Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Fleischhacker

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Psychological Medicine|March 24, 2011
Symptomatic remission and neurocognitive functioning in patients with schizophreniaA Hofer, T Bodner, A Kaufmann, et al.
Pharmacopsychiatry|January 21, 2009
Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective studyA Tschoner, J Engl, M Rettenbacher, et al.
The Journal of Nervous and Mental Disease|June 1, 1995
Tardive dyskinesia prevalence rates during a ten-year follow-upC H Miller, I Simioni, H Oberbauer, et al.
Neuroscience Letters|November 20, 2003
Brain activation pattern during a verbal fluency test in healthy male and female volunteers: a functional magnetic resonance imaging studyE M Weiss, C Siedentopf, A Hofer, et al.
Psychological Medicine|November 22, 2011
Unmet needs in patients with first-episode schizophrenia: a longitudinal perspectiveK Landolt, W Rössler, T Burns, et al.
Neuroscience Letters|June 19, 2003
Sex differences in brain activation pattern during a visuospatial cognitive task: a functional magnetic resonance imaging study in healthy volunteersE Weiss, C M Siedentopf, A Hofer, et al.
Schizophrenia Research|August 5, 1998
Hippocampal volume reduction in male schizophrenic patientsA B Whitworth, M Honeder, C Kremser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
The impact of hemoglobin levels on fatigue and quality of life in cancer patientsB Holzner, G Kemmler, R Greil, et al.
Psychopharmacology|October 1, 1995
Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophreniaJ A Den Boer, H J van Megen, W W Fleischhacker, et al.
Psychopharmacology|June 1, 1994
Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophreniaH J Möller, H M van Praag, B Aufdembrinke, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Psychological Medicine|March 24, 2011
Symptomatic remission and neurocognitive functioning in patients with schizophreniaA Hofer, T Bodner, A Kaufmann, et al.
Pharmacopsychiatry|January 21, 2009
Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective studyA Tschoner, J Engl, M Rettenbacher, et al.
The Journal of Nervous and Mental Disease|June 1, 1995
Tardive dyskinesia prevalence rates during a ten-year follow-upC H Miller, I Simioni, H Oberbauer, et al.
Neuroscience Letters|November 20, 2003
Brain activation pattern during a verbal fluency test in healthy male and female volunteers: a functional magnetic resonance imaging studyE M Weiss, C Siedentopf, A Hofer, et al.
Psychological Medicine|November 22, 2011
Unmet needs in patients with first-episode schizophrenia: a longitudinal perspectiveK Landolt, W Rössler, T Burns, et al.
Neuroscience Letters|June 19, 2003
Sex differences in brain activation pattern during a visuospatial cognitive task: a functional magnetic resonance imaging study in healthy volunteersE Weiss, C M Siedentopf, A Hofer, et al.
Schizophrenia Research|August 5, 1998
Hippocampal volume reduction in male schizophrenic patientsA B Whitworth, M Honeder, C Kremser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
The impact of hemoglobin levels on fatigue and quality of life in cancer patientsB Holzner, G Kemmler, R Greil, et al.
Psychopharmacology|October 1, 1995
Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophreniaJ A Den Boer, H J van Megen, W W Fleischhacker, et al.
Psychopharmacology|June 1, 1994
Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophreniaH J Möller, H M van Praag, B Aufdembrinke, et al.
Pageof 13